Home › Funds › Avoro Capital Advisors LLC › CYTK

Avoro Capital Advisors LLC position in CYTK

CYTOKINETICS INC · Health Care

Avoro Capital Advisors LLC reported holding 4,900,000 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$323.0M, representing 3.34% of its reported portfolio and ranking #9 among its reported holdings. Avoro Capital Advisors LLC has disclosed CYTK holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)4.90M sh
Reported value held$322.96M
Portfolio Weight3.34%
First reportedQ1 2026
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Avoro Capital Advisors LLC's CYTK position evolved

Avoro Capital Advisors LLC first disclosed a stake in CYTK in Q1 2026 at 3,333,333 shares (US$219.7M). The position peaked in Q2 2026 at 4,999,999 shares, worth US$425.9M. Across 3 filings, Avoro Capital Advisors LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,900,000 shares valued at US$323.0M — a reduction of -99,999 shares quarter over quarter.. Notable position changes include a 50% increase in Q2 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 3.33M $219.70M New
Q2 2026 5.00M $425.95M Add
Q3 2026 4.90M $322.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 39 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Polar Capital Holdings Plc (US$227.7M), RTW INVESTMENTS, LP (US$188.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has Avoro Capital Advisors LLC held CYTK?

Avoro Capital Advisors LLC has disclosed CYTK holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Avoro Capital Advisors LLC's current position in CYTK?

As of Q3 2026, Avoro Capital Advisors LLC holds 4.90M shares of CYTK (CYTOKINETICS INC), valued at $322.96M, representing 3.34% of its reported portfolio and ranking #9.

Has Avoro Capital Advisors LLC been buying or selling CYTK?

In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC reduced its position in CYTK. The position peaked in Q2 2026 at 5.00M shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Polar Capital Holdings Plc, RTW INVESTMENTS, LP, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.